The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / These Digital Tools Aren’t Just Hype, Can Actually Help Rheumatologists

These Digital Tools Aren’t Just Hype, Can Actually Help Rheumatologists

February 18, 2019 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Medication Adherence

Researchers are also turning to technology to monitor patients’ medication adherence, a huge but often overlooked problem, said Bernard Vrijens, PhD, chief executive officer at Advanced Analytical Research on Drug Exposure.

You Might Also Like
  • Tips for Using Digital Health Tools
  • 7 Smartphone Tools for Rheumatologists
  • Digital Footprints: Managing Your Online Professional Presence
Explore This Issue
February 2019
Also By This Author
  • Early Consults, Timely Patient Histories Aid Rheumatologists Treating Patients in the ICU

“When we have suboptimal adherence in practice, typically it leads to treatment failure,” Dr. Vrijens said. “When the treatment fails, the disease progresses. Sometimes we have acute events. And when the disease progresses, what we typically do is give more complex treatments. The more complex the treatment, the worse is the adherence. This is an extremely costly loop.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many apps push patients to take their medications, Dr. Vrijens noted. But they simply give alerts and aren’t integrated into a patient’s overall health picture. “Outcome is key. It’s not [about] taking the medication, it’s really [about] optimizing outcome, minimizing adverse effects.”

In research he has led, investigators use electronic monitoring to assess patients’ adherence—the act of a patient removing a pill from its container is recorded. The results show how vastly different patients’ adherence can be even if, overall, they have the same adherence rate.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

He showed data for six patients, all with an adherence rate of 81%. But one patient tended to be diligent in the morning while faltering at night. Another started out well and then began to deviate from the schedule. Another had such wild adherence that there was no clear pattern. These details—when patients didn’t take a pill or when they took double to make up for it—are important in making treatment decisions, Dr. Vrijens said. Research also suggests showing patients their own mistakes is the best way to improve their behavior.3

Adherence has become more important lately because new therapies tend to feature a narrow therapeutic window—too little delivers little effectiveness, and too much results in toxicity, he said.

“We need to bring knowledge to the point of care” to better individualize treatment, Dr. Vrijens said. “Medication adherence is really a vital sign to measure and manage in this setting of individualization of treatment.” 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Thomas R. Collins is a freelance writer living in South Florida.

References

  1. Bartlett SJ, Orbai AM, Duncan T. Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS One. 2015 Sep 17;10(9):e0138543.
  2. Gossec L, Guyard F, Leroy D, et al. Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: An application of machine-learning analyses in rheumatology. Arthritis Care Res (Hoboken). 2018 Sep 22.
  3. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs. 2013 May;73(6):545–562.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Meeting Reports, Technology Tagged With: 2018 ACR/ARHP Annual Meeting, adherence, patient data, PROMIS, wearable deviceIssue: February 2019

You Might Also Like:
  • Tips for Using Digital Health Tools
  • 7 Smartphone Tools for Rheumatologists
  • Digital Footprints: Managing Your Online Professional Presence
  • Doctors Who Take Pharmaceutical Money Use Twitter to Hype Drugs

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.